Home » Archive

News

News, Syndication »

Celladon Could Go Far Under Servier Collaboration, Licensing Deal

Posted by sandiegobiotech February 25th, 2014 .
No Comments

San Diego-based Celladon (NASDAQ: CLDN) said it has granted France’s Servier an option to license a new class of small-molecule drugs that could someday be used to treat type 2 diabetes and other…

[[Click headline to continue reading.]]

More...

News, Syndication, UCSD News »

UC San Diego’s Mexico Moving Forward Symposium Examines 20 Years of NAFTA

Posted by sandiegobiotech February 24th, 2014 .
No Comments

Mexico’s most visionary leaders, vibrant culture, past accomplishments and future goals will be the focus of the University of California, San Diego’s Mexico Moving Forward symposium, from 8:30 a.m. to 6 p.m. on March 6. The symposium, hosted by the Center for U.S.-Mexican Studies at the School of International Relations and Pacific Studies, will focus on Mexico’s progress and future goals 20 years after the signing of the North American Free Trade Agreement (NAFTA). It also will feature University of California President Janet Napolitano, UC San Diego Chancellor Pradeep K. Khosla and the School of International Relations and Pacific Studies Dean Peter Cowhey, as well as experts from both sides of the border.

More...

News, Syndication »

DexCom’s Revenue UP, Losses Down for Recent Quarter, Year

Posted by sandiegobiotech February 24th, 2014 .
No Comments

DexCom Inc., a biotech company specializing in glucose monitoring, reported revenue of $160 million for the year ended Dec. 31, 2013, a 60 percent increase from 2012, while its losses were down considerably.

More...

News, Syndication, UCSD News »

California’s First MRI-Guided Laser Treatment for Brain Cancer

Posted by sandiegobiotech February 24th, 2014 .
No Comments

Using a novel magnetic resonance imaging (MRI)-guided laser technology, neurosurgeons at UC San Diego Health System have successfully treated a malignant tumor deep inside a patient’s brain. This is the first time that this FDA-approved laser-based treatment has been performed in California.

More...

News, Syndication, UCSD News »

Study Evaluates Role of Infliximab in Treating Kawasaki Disease

Posted by sandiegobiotech February 24th, 2014 .
No Comments

A study led by physicians at the University of California, San Diego School of Medicine and Rady Children’s Hospital-San Diego looked at intensification of initial therapy for all children with Kawasaki Didease in order to prevent IVIG-resistance and associated coronary artery abnormalities by assessing the addition of the medication infliximab to current standard therapy.

More...

News, Syndication »

Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day

Posted by sandiegobiotech February 24th, 2014 .
No Comments

People who appreciate baseball stats agree: Jonny Gomes of the Boston Red Sox is a below-average player. Yet, if you pay attention to his intangibles, he looks better. Even with lousy performance…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

“All Hat, Ton of Cattle…”

Posted by sandiegobiotech February 22nd, 2014 .
No Comments

Had a remarkable day Friday in Houston crawling around the Texas Medical Center. I was in town to speak at the Xconomy Healthcare Summit—an incredible roster of speakers and attendees, I must…

[[Click headline to continue reading.]]

More...

News, Syndication, UCSD News »

In Memoriam: Calit2 Advisory Board Member Phil Smith (1932-2014)

Posted by sandiegobiotech February 21st, 2014 .
No Comments

Philip M. Smith, the founding co-chair of the California Institute for Telecommunications and Information Technology (Calit2) Advisory Board, passed away on February 16, 2014, after a brief illness.

More...

News, Syndication »

Dr. Scott Peterson presents “Your Microbiome and You: What Clinicians Need to Know”

Posted by sandiegobiotech February 21st, 2014 .
No Comments

Helicobacter pylori (H. pylori) is a type of bacterium that is found in the stomach of about two-thirds of the world’s population.

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Lithera, CardioCell, and More

Posted by sandiegobiotech February 21st, 2014 .
No Comments

ResMed founder Peter Farrell was characteristically outspoken, funny, and acerbic as he talked about the origins of Carlsbad-based ResMed at a luncheon in his honor. I have the details, along with…

[[Click headline to continue reading.]]

More...